The Effect of Using PARO for People Living With Dementia and Chronic Pain: A Pilot Randomized Controlled Trial

Lihui Pu; Wendy Moyle; Cindy Jones; Michael Todorovic

doi:10.1016/j.jamda.2020.01.014

The Effect of Using PARO for People Living With Dementia and Chronic Pain: A Pilot Randomized Controlled Trial

Lihui Pu, Wendy Moyle, Cindy Jones, Michael Todorovic

Faculty of Health Sciences & Medicine

Research output: Contribution to journal › Article › Research › peer-review

44 Citations (Scopus)

Abstract

OBJECTIVES: To evaluate the effect of interaction with a robotic seal (PARO) on pain and behavioral and psychological symptoms of people with dementia and chronic pain.

DESIGN: A parallel pilot randomized controlled trial conducted between January 2018 and January 2019.

SETTING: Three long-term care facilities in Australia.

PARTICIPANTS: Forty-three participants aged ≥65 years living with dementia and chronic pain.

INTERVENTION: Participants were randomized to the PARO group (individual, nonfacilitated, 30-minute sessions, 5 days per week for 6 weeks) or a usual care group using a computer-generated random number.

MEASUREMENTS: The primary outcome was researcher-rated observational pain behaviors before and after each session. Secondary outcomes were staff-rated pain level, agitation, depression, and anxiety measured at baseline and the end of week 6. Medications regularly prescribed and as needed were recorded weekly. Analyses followed intention-to-treat, using the generalized estimating equation model. Australian New Zealand Clinical Trials Registry (ACTRN12618000082202).

RESULTS: Participants in the PARO group had a significantly lowered level of observed pain [-0.514, 95% confidence interval (CI) -0.774 to -0.254, P < .001] and used fewer pro re nata medications (-1.175, 95% CI -2.205 to -0.145, P = .025) than those in usual care after controlling for age, sex, cognitive function and medications. There were no significant differences in staff-rated pain, agitation, anxiety, and depression, nor regularly scheduled medications between intervention and control group.

CONCLUSIONS AND IMPLICATIONS: PARO shows promise in reducing pain and medications for individuals with dementia and chronic pain in long-term care facilities. This intervention might be incorporated into daily practice as an alternative to manage pain in people with dementia. Larger randomized controlled trials with longer time frames are needed to identify further and test the use of PARO in long-term care settings.

Original language	English
Pages (from-to)	1079-1085
Number of pages	7
Journal	Journal of the American Medical Directors Association
Volume	21
Issue number	8
Early online date	28 Feb 2020
DOIs	https://doi.org/10.1016/j.jamda.2020.01.014
Publication status	Published - Aug 2020

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.jamda.2020.01.014

Cite this

@article{49f76db744ac432e86e636040249f482,

title = "The Effect of Using PARO for People Living With Dementia and Chronic Pain: A Pilot Randomized Controlled Trial",

abstract = "OBJECTIVES: To evaluate the effect of interaction with a robotic seal (PARO) on pain and behavioral and psychological symptoms of people with dementia and chronic pain.DESIGN: A parallel pilot randomized controlled trial conducted between January 2018 and January 2019.SETTING: Three long-term care facilities in Australia.PARTICIPANTS: Forty-three participants aged ≥65 years living with dementia and chronic pain.INTERVENTION: Participants were randomized to the PARO group (individual, nonfacilitated, 30-minute sessions, 5 days per week for 6 weeks) or a usual care group using a computer-generated random number.MEASUREMENTS: The primary outcome was researcher-rated observational pain behaviors before and after each session. Secondary outcomes were staff-rated pain level, agitation, depression, and anxiety measured at baseline and the end of week 6. Medications regularly prescribed and as needed were recorded weekly. Analyses followed intention-to-treat, using the generalized estimating equation model. Australian New Zealand Clinical Trials Registry (ACTRN12618000082202).RESULTS: Participants in the PARO group had a significantly lowered level of observed pain [-0.514, 95% confidence interval (CI) -0.774 to -0.254, P < .001] and used fewer pro re nata medications (-1.175, 95% CI -2.205 to -0.145, P = .025) than those in usual care after controlling for age, sex, cognitive function and medications. There were no significant differences in staff-rated pain, agitation, anxiety, and depression, nor regularly scheduled medications between intervention and control group.CONCLUSIONS AND IMPLICATIONS: PARO shows promise in reducing pain and medications for individuals with dementia and chronic pain in long-term care facilities. This intervention might be incorporated into daily practice as an alternative to manage pain in people with dementia. Larger randomized controlled trials with longer time frames are needed to identify further and test the use of PARO in long-term care settings.",

author = "Lihui Pu and Wendy Moyle and Cindy Jones and Michael Todorovic",

year = "2020",

month = aug,

doi = "10.1016/j.jamda.2020.01.014",

language = "English",

volume = "21",

pages = "1079--1085",

journal = "Journal of the American Medical Directors Association",

issn = "1525-8610",

publisher = "Elsevier",

number = "8",

}

TY - JOUR

T1 - The Effect of Using PARO for People Living With Dementia and Chronic Pain: A Pilot Randomized Controlled Trial

AU - Pu, Lihui

AU - Moyle, Wendy

AU - Jones, Cindy

AU - Todorovic, Michael

PY - 2020/8

Y1 - 2020/8

N2 - OBJECTIVES: To evaluate the effect of interaction with a robotic seal (PARO) on pain and behavioral and psychological symptoms of people with dementia and chronic pain.DESIGN: A parallel pilot randomized controlled trial conducted between January 2018 and January 2019.SETTING: Three long-term care facilities in Australia.PARTICIPANTS: Forty-three participants aged ≥65 years living with dementia and chronic pain.INTERVENTION: Participants were randomized to the PARO group (individual, nonfacilitated, 30-minute sessions, 5 days per week for 6 weeks) or a usual care group using a computer-generated random number.MEASUREMENTS: The primary outcome was researcher-rated observational pain behaviors before and after each session. Secondary outcomes were staff-rated pain level, agitation, depression, and anxiety measured at baseline and the end of week 6. Medications regularly prescribed and as needed were recorded weekly. Analyses followed intention-to-treat, using the generalized estimating equation model. Australian New Zealand Clinical Trials Registry (ACTRN12618000082202).RESULTS: Participants in the PARO group had a significantly lowered level of observed pain [-0.514, 95% confidence interval (CI) -0.774 to -0.254, P < .001] and used fewer pro re nata medications (-1.175, 95% CI -2.205 to -0.145, P = .025) than those in usual care after controlling for age, sex, cognitive function and medications. There were no significant differences in staff-rated pain, agitation, anxiety, and depression, nor regularly scheduled medications between intervention and control group.CONCLUSIONS AND IMPLICATIONS: PARO shows promise in reducing pain and medications for individuals with dementia and chronic pain in long-term care facilities. This intervention might be incorporated into daily practice as an alternative to manage pain in people with dementia. Larger randomized controlled trials with longer time frames are needed to identify further and test the use of PARO in long-term care settings.

AB - OBJECTIVES: To evaluate the effect of interaction with a robotic seal (PARO) on pain and behavioral and psychological symptoms of people with dementia and chronic pain.DESIGN: A parallel pilot randomized controlled trial conducted between January 2018 and January 2019.SETTING: Three long-term care facilities in Australia.PARTICIPANTS: Forty-three participants aged ≥65 years living with dementia and chronic pain.INTERVENTION: Participants were randomized to the PARO group (individual, nonfacilitated, 30-minute sessions, 5 days per week for 6 weeks) or a usual care group using a computer-generated random number.MEASUREMENTS: The primary outcome was researcher-rated observational pain behaviors before and after each session. Secondary outcomes were staff-rated pain level, agitation, depression, and anxiety measured at baseline and the end of week 6. Medications regularly prescribed and as needed were recorded weekly. Analyses followed intention-to-treat, using the generalized estimating equation model. Australian New Zealand Clinical Trials Registry (ACTRN12618000082202).RESULTS: Participants in the PARO group had a significantly lowered level of observed pain [-0.514, 95% confidence interval (CI) -0.774 to -0.254, P < .001] and used fewer pro re nata medications (-1.175, 95% CI -2.205 to -0.145, P = .025) than those in usual care after controlling for age, sex, cognitive function and medications. There were no significant differences in staff-rated pain, agitation, anxiety, and depression, nor regularly scheduled medications between intervention and control group.CONCLUSIONS AND IMPLICATIONS: PARO shows promise in reducing pain and medications for individuals with dementia and chronic pain in long-term care facilities. This intervention might be incorporated into daily practice as an alternative to manage pain in people with dementia. Larger randomized controlled trials with longer time frames are needed to identify further and test the use of PARO in long-term care settings.

UR - http://www.scopus.com/inward/record.url?scp=85080025046&partnerID=8YFLogxK

U2 - 10.1016/j.jamda.2020.01.014

DO - 10.1016/j.jamda.2020.01.014

M3 - Article

C2 - 32122797

SN - 1525-8610

VL - 21

SP - 1079

EP - 1085

JO - Journal of the American Medical Directors Association

JF - Journal of the American Medical Directors Association

IS - 8

ER -

The Effect of Using PARO for People Living With Dementia and Chronic Pain: A Pilot Randomized Controlled Trial

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this